Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic tyrosinemia associated with 4-hydroxyphenylpyruvate dioxygenase deficiency with acute intermittent ataxia and without visceral and bone involvement.

× No keyword cloud information.

13 in total

1. Autoimmune thyroiditis in a case of tyrosinaemia type III.

Authors: P D'Eufemia; O Giardini; A Cantani; F Martino; R Finocchiaro
Journal: J Inherit Metab Dis Date: 1992 Impact factor: 4.982

2. Outcome of tyrosinaemia type III.

Authors: C J Ellaway; E Holme; S Standing; M A Preece; A Green; E Ploechl; M Ugarte; F K Trefz; J V Leonard
Journal: J Inherit Metab Dis Date: 2001-12 Impact factor: 4.982

3. Immunological abnormalities in a patient with tyrosinaemia type III.

Authors: P D D'Eufemia; R Finocchiaro; M Celli; L Viozzi; O Giardini
Journal: J Inherit Metab Dis Date: 1995 Impact factor: 4.982

4. Benign tyrosinaemia: an 18-year follow-up.

Authors: G Stoppoloni; R Santinelli; F Prisco; G Canino; D Iafusco; F Di Palma
Journal: J Inherit Metab Dis Date: 1995 Impact factor: 4.982

5. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.

Authors: F Endo; H Katoh; I Matsuda
Journal: J Inherit Metab Dis Date: 1990 Impact factor: 4.982

6. A murine model for type III tyrosinemia: lack of immunologically detectable 4-hydroxyphenylpyruvic acid dioxygenase enzyme protein in a novel mouse strain with hypertyrosinemia.

Authors: F Endo; H Katoh; S Yamamoto; I Matsuda
Journal: Am J Hum Genet Date: 1991-04 Impact factor: 11.025

7. Nitisinone in the treatment of hereditary tyrosinaemia type 1.

Authors: Patrick J McKiernan
Journal: Drugs Date: 2006 Impact factor: 9.546

Review 8. From toxicological problem to therapeutic use: the discovery of the mode of action of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione (NTBC), its toxicology and development as a drug.

Authors: E A Lock; M K Ellis; P Gaskin; M Robinson; T R Auton; W M Provan; L L Smith; M P Prisbylla; L C Mutter; D L Lee
Journal: J Inherit Metab Dis Date: 1998-08 Impact factor: 4.982

9. Therapeutic trials in the murine model of hereditary tyrosinaemia type I: a progress report.

Authors: M Grompe; K Overturf; M al-Dhalimy; M Finegold
Journal: J Inherit Metab Dis Date: 1998-08 Impact factor: 4.982

Review 10. Hepatorenal tyrosinemia.

Authors: Teruo Kitagawa
Journal: Proc Jpn Acad Ser B Phys Biol Sci Date: 2012 Impact factor: 3.493